Show simple item record

AuthorBastaki, Kholoud
AuthorVelayutham, Dinesh
AuthorIrfan, Areeba
AuthorAdnan, Mohd
AuthorMohammed, Sawsan
AuthorMbarek, Hamdi
AuthorQoronfleh, Walid
AuthorJithesh, Puthen Veettil
Available date2024-03-24T05:29:38Z
Publication Date2024-03-18
Publication NameFrontiers in Public Health
Identifierhttp://dx.doi.org/10.3389/fpubh.2024.1364221
CitationBastaki K, Velayutham D, Irfan A, Adnan M, Mohammed S, Mbarek H, Qoronfleh MW and Jithesh PV (2024) Forging the path to precision medicine in Qatar: a public health perspective on pharmacogenomics initiatives. Front. Public Health. 12:1364221. doi: 10.3389/fpubh.2024.1364221
URIhttp://hdl.handle.net/10576/53373
AbstractPharmacogenomics (PGx) is an important component of precision medicine that promises tailored treatment approaches based on an individual’s genetic information. Exploring the initiatives in research that help to integrate PGx test into clinical setting, identifying the potential barriers and challenges as well as planning the future directions, are all important for fruitful PGx implementation in any population. Qatar serves as an exemplar case study for the Middle East, having a small native population compared to a diverse immigrant population, advanced healthcare system, national genome program, and several educational initiatives on PGx and precision medicine. This paper attempts to outline the current state of PGx research and implementation in Qatar within the global context, emphasizing ongoing initiatives and educational efforts. The inclusion of PGx in university curricula and healthcare provider training, alongside precision medicine conferences, showcase Qatar’s commitment to advancing this field. However, challenges persist, including the requirement for population specific implementation strategies, complex genetic data interpretation, lack of standardization, and limited awareness. The review suggests policy development for future directions in continued research investment, conducting clinical trials for the feasibility of PGx implementation, ethical considerations, technological advancements, and global collaborations to overcome these barriers.
SponsorThe author(s) declare financial support was received for the research, authorship, and/or publication of this article. Funding from the Qatar University and Hamad Bin Khalifa University are greatly acknowledged. The funders had no role in the study design, analysis or reporting.
Languageen
PublisherFrontiers Media
Subjectpharmacogenomics (PGx)
population health
precision health
precision medicine
Middle East
Qatar
TitleForging the Path to Precision Medicine in Qatar: A Public Health Perspective on Pharmacogenomics Initiatives
TypeArticle Review
Volume Number12
ESSN2296-2565
dc.accessType Open Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record